Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)

Clinical trial NCT00638963 · TERMINATED

Trial details

NCT number: NCT00638963
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm Brain Neoplasm Second Neoplasm

Start date: 2008-10-02
Primary completion: 2010-06-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.